NCT06537882View on ClinicalTrials.gov

Evaluate the Effect of Synbiotics on MAFLD

NAActive, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 17, 2024

Primary Completion Date

February 7, 2025

Study Completion Date

June 30, 2026

Conditions
Metabolic Dysfunction-Associated Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

G-NiiB synbiotics formula (SLP07)

SLP07 consists of a blend of food-grade Bifidobacterium and Lactobacillus as active probiotics, omega 3, and vitamin E.

DIETARY_SUPPLEMENT

Active placebo

Active placebo contains 2mg of vitamin C with corn starch filler

Trial Locations (1)

Unknown

GenieBiome Limited, Hong Kong

All Listed Sponsors
collaborator

Microbiota I-Centre (MagIC)

UNKNOWN

lead

GenieBiome Limited

INDUSTRY

NCT06537882 - Evaluate the Effect of Synbiotics on MAFLD | Biotech Hunter | Biotech Hunter